AVAX long-term target looks towards $27, prices rebound above $10.55, ETF inflows increase

AVAX突破$10.55关口，长期目标指向$27

Avalanche（AVAX）在从$9.98的局部低点反弹后展现出强劲势头，构筑了一系列更高的低点，并成功突破了此前的短期阻力位。这一复苏行情使交易员将目光重新聚焦于关键的$10.96水平，若当前动能持续，市场已设定了多个更高的目标价位。

稳固支撑形成，$10.96成为关键转折点

自触及$9.98以来，Avalanche建立了更为坚实的技术结构，呈现出连续的低点抬升态势。AVAX近期突破了曾限制此前反弹的$10.75阻力位。技术分析师Alex Marzell在X平台发布观点指出，AVAX在突破后触及约$10.96的水平，尽管在该高点出现短暂回调。目前代币价格稳定在$10.55上方，该位置已从阻力转变为短期趋势的重要支撑位。

只要价格能维持在$10.55之上，突破行情便有望延续，并为再次向上挑战$10.96留下空间。然而，如果AVAX跌破这一防线，则可能表明最新的反弹仅为暂时现象，下行压力或将重现。Marzell的图表强调了$10.55处的新短期支撑，指出守住这一水平对于维持突破动能以及向$10.96发起新一轮冲击至关重要。

看涨信号显现，多年形成的楔形形态迎来突破契机

The broader technical aspects are also improving. For the past few years, Avalanche has been trading in a broad declining wedge that began in the 2021 market cycle. An analyst named Moustache shared a three-week chart showing AVAX rebounded from the lower wedge boundary ($6 to $7 range) and is now climbing into the $10-$11 region.

Momentum is gathering: The three-week MACD (Smooth Similarities and Differences Moving Average), a long-term technical indicator, is turning upward after experiencing negative areas, seeking bullish cross confirmation. The contraction in the short bar chart suggests that the downward momentum is weakening. Still, as the MACD signal has not yet been finalized, a comprehensive bullish confirmation still needs to be awaited.

The upper boundary of the wedge is currently between $24 and $28, while the mid-term resistance level is $16-$18. To confirm a lasting shift in trends, AVAX must overcome these barriers.

Terminology analysis:
MACD (Moving Average Convergence Divergence) is a trend-following momentum indicator used to display the relationship between two moving averages of securities prices. It is often used to identify changes in trend strength, direction, momentum and duration.

Recovery targets: $17,$22 and $27

AVAX is currently approaching the key medium-term resistance area identified by analyst Michaël van de Poppe. He pointed out that breaking through current resistance could activate the next stage of recovery. The first major goal is around $17, and then $22 will become the next major obstacle. If the trend remains intact and buying pressure continues,$27 is expected to become a long-term achievable goal.

Analysts emphasize that only by confirming breakthroughs and continuing to hold gains above each subsequent target can we advance to the next stage. Michaël van de Poppe's outlook outlines a path starting from the support level of $10.55 and leading to a potential breakthrough of $10.96 to $17 and $22; if technical conditions remain favorable,$27 is considered the main long-term forecast target.

ETF capital inflows strengthen fundamentals

As the price structure continues to improve, the market demand for Avalanche investment products is also increasing. The Avalanche ETF issued by Bitwise recorded a weekly net inflow of approximately $231,000, the second-highest inflow record for the quarter. The increase occurred during the AVAX recovery and suggests that institutional and investor attention is picking up.

Although ETF inflows themselves cannot directly determine price movements, increased investment activity complements the bullish technical aspects, further consolidating the recovery narrative.

Terminology:
Bitwise is a leading digital asset management company that provides cryptocurrency index funds and ETF products to institutional and individual investors.

Risk and downside considerations

Despite signs of improvement, Avalanche still needs to overcome several important technical hurdles. A break below $10.55 would weaken the bullish outlook and bring the $9.98 low back into focus. Any failure to break at $10.96 could hinder the recovery process, and unresolved MACD momentum means the trend is still not fully confirmed. Until the possibility of hitting $27 arises, the $16-$18 area and the wedge upper boundary remain major challenges.

AVAX is currently trading at around $10.54, up about 1% in the past 24 hours. Maintaining support and overcoming key resistance levels will be key to AVAX's continued recovery and moving towards long-term goals.